Literature DB >> 8018765

Myelodysplastic syndromes in childhood: description of seven cases.

A Vitale1, A M Testi, M L Moleti, M Vignetti, W Arcese, S Fenu, M Cedrone, L De Felice, S Amadori, F Mandelli.   

Abstract

Seven children with a primary myelodysplastic syndrome were seen at our center over a 9-year period. Two presented with refractory anemia, three with refractory anemia with excess of blasts, and two with refractory anemia with excess of blasts in transformation. All children received supportive therapy, including blood transfusions in five of them. Three patients developed acute myeloid leukemia and were treated with intensive chemotherapy, followed by allogeneic or autologous marrow transplantation in the two responders. All three died of either infection or progressive disease. The other four patients are still alive a median of 71 months (range 38-130) after diagnosis. These results confirm the difficulties in managing patients with myelodysplastic syndromes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8018765     DOI: 10.1007/bf01737424

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  32 in total

1.  Human bone marrow colony growth in agar-gel.

Authors:  B L Pike; W A Robinson
Journal:  J Cell Physiol       Date:  1970-08       Impact factor: 6.384

Review 2.  The myelodysplastic syndrome--a practical guide.

Authors:  T J Hamblin; D G Oscier
Journal:  Hematol Oncol       Date:  1987 Jan-Mar       Impact factor: 5.271

3.  Colony-cluster ratio and cluster number in cultures of circulating myeloid progenitors as indicators of high-risk myelodysplasia.

Authors:  G B Tennant; D T Bowen; A Jacobs
Journal:  Br J Haematol       Date:  1991-03       Impact factor: 6.998

4.  Mitoxantrone, etoposide, and intermediate-dose cytarabine: an effective and tolerable regimen for the treatment of refractory acute myeloid leukemia.

Authors:  S Amadori; W Arcese; G Isacchi; G Meloni; M C Petti; B Monarca; A M Testi; F Mandelli
Journal:  J Clin Oncol       Date:  1991-07       Impact factor: 44.544

5.  Allogeneic bone marrow transplantation for secondary leukaemia and myelodysplastic syndrome: a survey by the Leukaemia Working Party of the European Bone Marrow Transplantation Group (EBMTG)

Authors:  T De Witte; F Zwaan; J Hermans; J Vernant; H Kolb; J Vossen; B Lönnqvist; D Beelen; A Ferrant; J Gmür
Journal:  Br J Haematol       Date:  1990-02       Impact factor: 6.998

6.  Treatment of acute myelogenous leukemia in children: results of the Italian Cooperative Study AIEOP/LAM 8204.

Authors:  S Amadori; A Ceci; A Comelli; E Madon; G Masera; L Nespoli; G Paolucci; L Zanesco; A Covelli; F Mandelli
Journal:  J Clin Oncol       Date:  1987-09       Impact factor: 44.544

7.  Myelodysplastic syndromes in childhood: three case reports.

Authors:  E R van Wering; W A Kamps; J M Vossen; C J van der List-Nuver; P M Theunissen
Journal:  Br J Haematol       Date:  1985-05       Impact factor: 6.998

8.  The myelodysplastic syndromes: different evolution patterns based on sequential morphological and cytogenetic investigations.

Authors:  G Tricot; M A Boogaerts; C De Wolf-Peeters; H Van den Berghe; R L Verwilghen
Journal:  Br J Haematol       Date:  1985-04       Impact factor: 6.998

9.  Leukemia after therapy with alkylating agents for childhood cancer.

Authors:  M A Tucker; A T Meadows; J D Boice; M Stovall; O Oberlin; B J Stone; J Birch; P A Voûte; R N Hoover; J F Fraumeni
Journal:  J Natl Cancer Inst       Date:  1987-03       Impact factor: 13.506

10.  The prognostic value of chromosome studies in patients with the preleukemic syndrome (hemopoietic dysplasia).

Authors:  R L Anderson; G C Bagby
Journal:  Leuk Res       Date:  1982       Impact factor: 3.156

View more
  1 in total

1.  Myelodysplasia in children.

Authors:  Urmila N Khadilkar; Jyostna P Dayal
Journal:  Indian J Pediatr       Date:  2002-04       Impact factor: 1.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.